Benjamin F. Edwards & Company, Inc. Bio Rad Laboratories, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 50 shares of BIO stock, worth $13,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 56
10.71%
Holding current value
$13,216
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BIO
# of Institutions
444Shares Held
19.7MCall Options Held
12.7KPut Options Held
14.4K-
First Eagle Investment Management, LLC2.52MShares$665 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$505 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$410 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$241 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$232 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.51B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...